연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Molecular Oncology
Federico Caligaris-Cappio has not added Biography.
If you are Federico Caligaris-Cappio and would like to personalize this page please email our Author Liaison for assistance.
Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.
Nature medicine Jun, 2014 | Pubmed ID: 24813251
Anergy: the CLL cell limbo.
Blood May, 2014 | Pubmed ID: 24855189
SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.
Haematologica Aug, 2014 | Pubmed ID: 24859880
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
The New England journal of medicine Jul, 2014 | Pubmed ID: 24881631
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
British journal of haematology Oct, 2014 | Pubmed ID: 25312994
IRCCS, San Raffaele Scientific Institute
Università Vita-Salute San Raffaele
Benedetta Apollonio1,2,
Maria Teresa Sabrina Bertilaccio1,
Umberto Restuccia3,
Pamela Ranghetti1,
Federica Barbaglio1,
Paolo Ghia1,4,
Federico Caligaris-Cappio1,4,
Cristina Scielzo1
1Division of Molecular Oncology, IRCCS, San Raffaele Scientific Institute,
2Department of Haemato-Oncology, King's College London,
3, IFOM, FIRC Institute of Molecular Oncology,
4, Università Vita-Salute San Raffaele
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유
